![Lewis Bender](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lewis Bender
Algemeen Directeur bij
INTENSITY THERAPEUTICS, INC.
Vermogen: 520 430 $ op 31-05-2026
Profiel
Lewis H.
Bender is the founder of Intensity Therapeutics, Inc., founded in 2012, where the titles held include Chairman, President & Chief Executive Officer.
Former jobs include Chief Executive Officer & Director at Interleukin Genetics, Inc. from 2011 to 2012, and President, CEO & Chief Technology Officer at Emisphere Technologies, Inc. from 1993 to 2007.
Education history includes graduate studies at the University of Pennsylvania, undergraduate and graduate degrees from the Massachusetts Institute of Technology, and an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-04-2026 | 118.549 ( 4,39% ) | 520 430 $ | 31-05-2026 |
Actieve functies van Lewis Bender
| Bedrijven | Functie | Begin |
|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Algemeen Directeur | 01-04-2012 |
Eerdere bekende functies van Lewis Bender
| Bedrijven | Functie | Einde |
|---|---|---|
| INTERLEUKIN GENETICS, INC | Algemeen Directeur | 23-08-2012 |
| EMISPHERE TECHNOLOGIES, INC. | Algemeen Directeur | 01-12-2007 |
Opleiding van Lewis Bender
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
37
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops personalized health products | Health Technology |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
